title: Novel 1,5-benzodiazepines as CCK-B ligands. Effect of aryl-carbamic substituents at the C-3 position together with halogen substitution on the benzo-fused ring.
authors.affiliation: Glaxo Wellcome S.p.A., Medicines Research Centre, Verona, Italy.
authors.forename: M E
authors.initials: ME
authors.lastname: Tranquillini
authors.forename: P G
authors.initials: PG
authors.lastname: Cassarà
authors.forename: M
authors.initials: M
authors.lastname: Corsi
authors.forename: G
authors.initials: G
authors.lastname: Curotto
authors.forename: D
authors.initials: D
authors.lastname: Donati
authors.forename: G
authors.initials: G
authors.lastname: Finizia
authors.forename: G
authors.initials: G
authors.lastname: Pentassuglia
authors.forename: S
authors.initials: S
authors.lastname: Polinelli
authors.forename: G
authors.initials: G
authors.lastname: Tarzia
authors.forename: A
authors.initials: A
authors.lastname: Ursini
authors.forename: F T
authors.initials: FT
authors.lastname: van Amsterdam
mesh_terms: D000818:Animals; D001569:Benzodiazepines / Q000138:chemical synthesis* / Q000378:metabolism* / Q000494:pharmacology; D006168:Guinea Pigs; D006846:Hydrocarbons, Halogenated / Q000138:chemical synthesis* / Q000378:metabolism* / Q000494:pharmacology; D007700:Kinetics; D008024:Ligands; D043887:Receptor, Cholecystokinin B; D011949:Receptors, Cholecystokinin / Q000378:metabolism*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
chemical_list: D006846:Hydrocarbons, Halogenated; D008024:Ligands; D043887:Receptor, Cholecystokinin B; D011949:Receptors, Cholecystokinin; D001569:Benzodiazepines